Systemic lysostaphin in man--apparent antimicrobial activity in a neutropenic patient.
D000380:Agranulocytosis / Q000150:complications*; D002481:Cellulitis / Q000188:drug therapy / Q000382:microbiology; D002512:Cephalothin / Q000494:pharmacology; D004341:Drug Evaluation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications; D008248:Lysostaphin / Q000627:therapeutic use*; D008297:Male; D008712:Methicillin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D011014:Pneumonia / Q000188:drug therapy / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013210:Staphylococcus / Q000187:drug effects / Q000302:isolation & purification; D014640:Vancomycin / Q000494:pharmacology
D014640:Vancomycin; D008248:Lysostaphin; D008712:Methicillin; D002512:Cephalothin